Gregory Stock TOPICS: Healthcare Technology Health Policy Biotechnology FEE CATEGORY:* Contact for fee schedule TRAVELS FROM: California Profile Books & Videos Request This Speaker

Gregory Stock: Profile

Best-selling author, scientist and educator, Gregory Stock, Director of the Program on Medicine, Technology and Society at UCLA's School of Medicine, is a pioneering advocate of strong biomedical research and pragmatic approaches to human genetic engineering. The Wall Street Journal hails Stock as one of the few serious scientists who publicly states that attempts to block cloning will fail and that regulation should not be based on exaggerated fears about the technology.

Never intimidated by controversy, Stock is featured as a regular guest on CNN, PBS, BBC and NPR. He has appeared on more than 1,500 radio and television programs. He has been called upon for his expertise by NASA, Lloyd's, Hewlett-Packard, GlaxoSmithKline and the President.

The genomics revolution is dramatically reshaping healthcare, pharmaceuticals and agriculture. Stock explains why its benefits far outweigh its risks and how new biomedical technologies will revolutionize these and other sectors of the economy. He continues to forcefully push for greater public and industry-wide awareness of these technologies and urges broad involvement in the ongoing debate about their use.

Enthusiastically inviting the audience to share his understandings of the promises and pitfalls of embryo screening, pharmacogenomics and other biomedical advances, Stock argues that unraveling human biology is our inevitable future and will put society in control of its own evolution.

Bringing to the podium a provocative message of practical science, Stock explores radical new possibilities that will affect everything from health insurance and drug approval to human life spans and the way we have children.

Stock holds a doctorate in biophysics from Johns Hopkins University and an M.B.A. from Harvard Business School. A prolific author and recognized authority on the impact of new technologies on society, Stock has published many books and hundreds of articles. Among his works is his #1 New York Times bestseller, The Book of Questions, which poses 250 questions that invite people to explore the most fascinating of subjects: themselves.

This bestseller has been translated into seventeen languages and has been expanded into a four-book series. His newest book, Redesigning Humans: Our Inevitable Genetic Future, analyzes how biotechnology will shape the human future.

Stock is the recipient of the Freund-Porter Entrepreneur-of-the-Year Award and the Jasse Award for Distinction in Leadership, both from Harvard. He has served on numerous scientific advisory boards and has founded several companies including Signum Biosciences, which is seeking treatments and preventives for Alzheimer's.




Programs:


Each program is individually tailored. Some examples:

Biotechnology And The Future Of Medicine And Healthcare

Unraveling The Workings Of Life - Implications For Industry, Society And The Human Future

Bio-technology, Bio-innovation, Bio-ethics

Infotech Meets Biotech: A Revolution In The Making

Our Biotech Future.

* Please note that while this speaker's specific fee falls within the range posted at the top of this page (for Continental U.S. based events), fees are subject to change without notice. Also note that most celebrity keynotes begin in the $25,000 and up range (most list "Contact for Fee Schedule"). For current fee information or international event fees, please contact your Speakers Platform representative.